1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow ESS: new trials by email Literature Review of ESS trials Research Report on ESS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph 2 Elacestrant in ER Positive Uterine Sarcomas Elacestrant - Uterine Sarcoma, Uterine Leiomyosarcoma | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 30 | 2026-03-25 | 2026-05-22 |
Adenosarcoma of the uterus (1) · Perivascular Epithelioid Cell Neoplasms (1) · Sarcoma, Endometrial Stromal (1)
Endometrial Neoplasms (1) · Endometrial Stromal Tumors (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Connective and Soft Tissue (1) · Sarcoma (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Diseases (1)
RAD1901 (1) · elacestrant (1)
Dana-Farber Cancer Institute (1)
United States (1)